Race
Sleep Heart Health Study (SHHS) Visit Number vs Days to Fatal Cardiovascular Disease (CVD) Since Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Visit 1 | - | - | - | - | - | - | - | - |
| Interim Follow-up Visit | - | - | - | - | - | - | - | - |
| Visit 2 | - | - | - | - | - | - | - | - |
| CVD Outcomes | 355 | 2,495.7 | ± 1,200.6 | 2,622.0 | 7.0 | 4,758.0 | 5,447 | 5,802 |
Gender of the participant vs Days to Fatal Cardiovascular Disease (CVD) Since Baseline
CVD Outcomes
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 355 | 2,495.7 | ± 1,200.6 | 2,622.0 | 7.0 | 4,758.0 | 5,447 | 5,802 |
| Male | 193 | 2,449.3 | ± 1,213.3 | 2,578.0 | 7.0 | 4,758.0 | 2,572 | 2,765 |
| Female | 162 | 2,550.9 | ± 1,186.7 | 2,688.5 | 99.0 | 4,500.0 | 2,875 | 3,037 |
Race of the participant vs Days to Fatal Cardiovascular Disease (CVD) Since Baseline
CVD Outcomes
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 355 | 2,495.7 | ± 1,200.6 | 2,622.0 | 7.0 | 4,758.0 | 5,447 | 5,802 |
| White | 307 | 2,508.4 | ± 1,204.9 | 2,655.0 | 7.0 | 4,758.0 | 4,600 | 4,907 |
| Black | 48 | 2,414.2 | ± 1,181.9 | 2,284.0 | 127.0 | 4,366.0 | 467 | 515 |
| Other | - | - | - | - | - | - | 380 | 380 |